ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KMK Kromek Group Plc

7.25
-0.25 (-3.33%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -3.33% 7.25 7.00 7.50 7.55 7.25 7.55 681,334 13:44:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.11 43.52M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 7.50p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.25p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £43.52 million. Kromek has a price to earnings ratio (PE ratio) of -7.11.

Kromek Share Discussion Threads

Showing 4476 to 4499 of 7250 messages
Chat Pages: Latest  182  181  180  179  178  177  176  175  174  173  172  171  Older
DateSubjectAuthorDiscuss
13/5/2021
12:52
In February , Kromek raised another £13m via a Placing and Open Offer.

I think that's the fifth fund-raising in 6 or 7 years.


In fairness, the CEO did take part in the fund-raising.


He subscribed for 16,750 shares for a value of £2,513.


ALL IMO. DYOR.
QP

quepassa
13/5/2021
11:40
The total amount of share purchases by all directors of Kromek in the last 6months. A company which is hovering around record lows - which is said to be 'back on track as commercial activities really ramp up’, a company with a new revolutionary detector in the pipeline... And the entire board have invested total of £10k?!?! This is a totally and utterly pathetic. If they have no confidence in Kromek, I’m seriously doubting why I should...
aqc888
13/5/2021
10:40
Always amazes me that posters expect employees at small companies, who probably don't get paid very much, to magic up hundreds of thousands of pounds to buy huge amounts of shares, whilst still expecting them to pay their mortgage and feed their kids.

Of course, I might be wrong and this guy could be a billionaire - but then why's he at a £65m mkt company.

Further to the second point, there are real security implications and trial effectiveness reasons for not announcing where these detectors are being used. The company works with highly security conscious organisations - what sensors and detectors are in use at Heathrow? Fact is virtually no one knows, and that is deliberate.

mauricemonkey
12/5/2021
19:06
maybe he's a bit skint! what do you want, a purchase of 500.000? or 2,000.000?
🤑

abbynat
12/5/2021
18:54
Maybe it was the Proactive interview which further added doubt and dubiousness.

It was just waffle.

Vague generalisations about being on track and ramping up. Heard it all before.

It all sounded so hollow and floundering. Nothing concrete. No facts or figures or hard detail.

Everyone interested in Kromek should listen to the interview.

The interviewer asked a question about the covid-sniffer-thingamajig in an airport but got a completely evasive answer.

No mention of the ventilators.

Listen to the Proactive interview.


ALL IMO. DYOR.
QP

quepassa
12/5/2021
18:32
Indeed ... if the Chairman had waited a couple of more hours before he bought'em then he would have got more shares for his GBP 10k :-)
livewireplus
12/5/2021
17:38
I really can’t understand this. Not the best RNS yesterday but not the worst either. And, although not the biggest share purchase by a BoD it’s still a purchase and the share price drops. This is like being poked in the eye!
b00mb0y
12/5/2021
17:32
Agreed, QuePassa. At least it’s a purchase but it would have been more inspiring for us PI’s to see something more encouraging.
b00mb0y
12/5/2021
16:29
well, i take that as a sign of little confidence if all the Chairman wants to invest is a diminutive ten grand.

that is not at all much skin in the game on a purchase.


ALL IMO. DYOR.
QP

quepassa
12/5/2021
16:15
.... they do seem to have issued the RNS quite swiftly .... share purchase at 12.12 and RNS at 14.50 ....
livewireplus
12/5/2021
16:10
Indeed - the non-exec Chairman splashed out GBP 10k.
livewireplus
12/5/2021
15:50
at last a director buy! about time too. new confidence, surely its up from here?
abbynat
12/5/2021
09:15
Arnab seemed to be blabbering a lot in that interview. It still seems, to me, that they need to get a move on and get some positive company landmark results.
b00mb0y
12/5/2021
08:38
Those recurring “if’s221; are are getting bigger and bigger as time passes by.
b00mb0y
12/5/2021
07:46
It all sounds very positive to me.
If the trails are as expected this will transform the outlook for Kmk for years to come.

33mick
11/5/2021
23:29
Bosbus - agreed, everything else, there or there abouts, was mullered today.
dougmachin
11/5/2021
19:29
Credit where it's due. I follow 100 companies on advfn and 88 of them are significantly down today. KMK is fourth highest riser out of the others
bosbus
11/5/2021
09:56
Yes 47fish by a country mile, DARPA have funded the Kromek patho design an all UK tech JUST because our British DNA/RNA gene sequencing tech is arguably the best in the world.

All the other attempts have used the very best patho gene tech available to them at conception.

Northrop spent millions on thier design, 2 or 3 versions over 5-6 years. They couldn't get cost down to a practical figure either..100 k per unit.

This is rightly as we're told by Kmk..it's never be done before...it hasn't ....this is the closest.

I don't give much time to the neg posters on here I must admit, it takes time to develop this kind of world first product which many here just don't twig.

Were not told which core tech Kmk are using are we.. but if you can add 2+2 it's obvious.

33mick
11/5/2021
09:53
ali47fish is the biggest MANIPULATOR on advfn.

he acts all innocent and tries to ask these innocuous sounding questions.

but all he is doing is trying to manipulate you into responding with a very positive answer.

wherever you see ali47fish on bulletin boards, it's always the same modus operandi.

for example - click on his username and you will see that this is what he does all the time.


if you don't mind be used and manipulated , go ahead and respond.

quepassa
11/5/2021
09:47
33 mick do you imply kmk's technology is better then?
ali47fish
11/5/2021
09:15
They never tell you anything really. Just vague generalisations with no concrete details.

Always gilded and always dressed up but with no real substance beneath

The market doesn't fall for it any more.


ALL IMO. DYOR.
QP

quepassa
11/5/2021
09:13
For refs above-



Northrop were using the latest PCR based patho detection available to them then...
Things have moved on considerably since then.





The States are still running a paper filter' system with 1000 personnel collecting and bagging /posting filters back to labs and waiting 36 hours to hear results, these filters collect everything in the air , brake dust (metros) being the biggest pollutant along with pollens, animal DNA human DNA all splattered over each other....it's a flawed system.

Costing some 70-80 million dollars a year to operate

33mick
11/5/2021
09:10
“ at an airport and at another public place”
Where, what is another public place?

“ progressing according to plan”
What exactly is/was the plan?

And so on that “great” news the share price takes a fall!

b00mb0y
11/5/2021
09:06
Biowatch

The States want to replace it's 20 year old 'collect and post paper filter' Bio detection system with an autonomous networked one. 'Lab in a box'

They almost did but it got cancelled (Gen 3) as its detectors only worked for a week before needing maintenance, caused multiple false +'s

Ref
LA Times
BY DAVID WILLMAN
APRIL 25, 2014 8:19 PM PT
WASHINGTON — Amid concerns about its effectiveness and multibillion-dollar cost, the Department of Homeland Security has canceled plans to install an automated technology that was meant to speed the 24-hour operations of BioWatch, the national system for detecting a biological attack.

The cancellation of the “Generation 3" acquisition was made Thursday at the direction of Homeland Security Secretary Jeh Johnson, according to a memorandum circulated by Michael V. Walter, the BioWatch program manager.

Homeland Security officials earlier had told companies interested in supplying the technology that it would spend $3.1 billion for it during the first five years of operation.

So the Gen 4? market for Homeland security is no small beer...

33mick
Chat Pages: Latest  182  181  180  179  178  177  176  175  174  173  172  171  Older

Your Recent History

Delayed Upgrade Clock